Pharmacology

Comparing Antithrombotic Regimens for Diabetic Patients Undergoing PCI

Fed Pract. 2010 January;27(1):32
PDF Download

 

Recommended Reading

Olmesartan Lowers Microalbuminuria in Type 2
Type 2 Diabetes ICYMI
Exenatide Gains Indication For Type 2 Monotherapy
Type 2 Diabetes ICYMI
Predialysis Hemoglobin Low In Diabetic Nephropathy
Type 2 Diabetes ICYMI
Acute MI Rates Differed With Types of Insulins
Type 2 Diabetes ICYMI
Diabetes-Related Visual Impairment Down 20%
Type 2 Diabetes ICYMI
HbA1c Levels Above 8% Pose All-Cause Mortality Risk
Type 2 Diabetes ICYMI
Uric Acid Marks Type 2
Type 2 Diabetes ICYMI
Do Diabetic Foot Clinics Spread MRSA?
Type 2 Diabetes ICYMI
Eplerenone Decreases Hospitalization Time
Type 2 Diabetes ICYMI
The Role of Incretin-Based Therapies in Treating Patients with Type 2 Diabetes Mellitus
Type 2 Diabetes ICYMI